Press & Publications

Curavac at the European Venture Contest, 9-10 December 2014

As one of the top scoring companies of the ENTENTE-Life Sciences Investment Forum, Curavac took part in the European Venture Contest and the European Venture Summit, the final event of the European Venture Contest, taking place on December 9th& 10th in Dusseldorf, Germany.

See the list of the top 25% of companies here:

http://www.e-unlimited.com/events/view.aspx?events_pages_id=2801

Curavac awarded best presentation at ENTENTE

Myasterix partner, Curavac, was among the 8 companies that received a prize for best presentation at ENTENTE.

Curavac was one of the 28 companies selected from a pool of 100 to present at the event. Their prize has qualified them to present at the European Venture Summit  in Dusseldorf, Germany on the 8-9 December 2014. 

Curavac was selected to present at ENTENTE 8-9 October 2014

Curavac, Scientific coordinator of Myasterix, was one of the 28 companies selected among 100 companies to present at ENTENTE which took place in Brussels on the 8-9 October during the European Biotechnology Week 2014.

http://entente-health.eu/Events/Future-Events/ENTENTE-Life-Sciences-Investment-Forum.kl#.VCqgm2d_tj4

Myasterix Annual Meeting, 26-27 September 2014, Graz, Austria

The Myasterix Annual Meeting was held in Graz, Austria on the 26-27 September 2014.

All partners were represented and members of the Independant Advisory Board and Ethics Operational Board participated.

The meeting was hosted by PiChem.

Subcategories